Metabolic Syndrome and Inflammatory Markers

This study has been completed.
Sponsor:
Information provided by:
Free Islamic University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00433082
First received: February 8, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted
  Purpose

The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.


Condition Intervention
Metabolic Syndrome
Behavioral: Ramadan Fasting

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effect of Fasting With Two Meals on Inflammatory Markers of Metabolic Syndrome

Resource links provided by NLM:


Further study details as provided by Free Islamic University of Medical Sciences:

Primary Outcome Measures:
  • Measuring inflammatory markers in metabolic syndrome

Study Start Date: August 2006
Estimated Study Completion Date: November 2006
  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Males with metabolic syndrome

Exclusion Criteria:

  • Conditions with insulin resistance including;
  • Type 2 diabetes mellitus,
  • Infections,
  • Stresses,
  • Uremia,
  • Acromegaly,
  • Glucocorticoid excess,
  • Hypertension ,
  • Cirrhosis and
  • Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00433082

Sponsors and Collaborators
Free Islamic University of Medical Sciences
Investigators
Principal Investigator: Zahra Vahdat Shariatpanahi, MD Islamic Free University of Medical Science
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00433082     History of Changes
Other Study ID Numbers: 1345104
Study First Received: February 8, 2007
Last Updated: February 8, 2007
Health Authority: Iran: Institutional Review Board

Keywords provided by Free Islamic University of Medical Sciences:
Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,
Iran

Additional relevant MeSH terms:
Metabolic Syndrome X
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on August 20, 2014